FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2254119765> ?p ?o ?g. }

• W2254119765 abstract "This retrospective multicenter analysis was aimed to evaluate clinical activity and tolerability of eribulin in pretreated metastatic breast cancer patients in clinical practice. Patients treated with eribulin from January 2012 to July 2013 were enrolled in the observational study from 10 italian hospitals. Tumor and toxicity evaluation were performed according to Agenzia Italiana Farmaco. One-hundred and thirteen patients were included in the study. Median age 62 years old. 71.7 % of the patients had visceral involvement and the majority had a burden of disease involving two or more organs with a median number of 2 (1–6). The median number of previous chemotherapy regimens for advanced disease was 3 (1–10). Median number of eribulin cycles was 4 (1–27). Overall response rate was 24 % (95 % CI 16.0–31.8). Clinical benefit rate, was 35.4 % (95 % CI 26.6–44.2). At a median follow-up of 29.6 months (8.3–41.9) the median progression free survival was 3.3 months (0.6–26.7; 95 % CI 2.4–4.2), and the median overall survival 11.6 months (0.6–33.3; 95 % CI 8.7–14.5). No correlation was recorded between subtypes in terms of ORR and CBR. Toxicity was manageable. Main common grade 3–4 toxicities were neutropenia (19.4 %), febrile neutropenia (0.9 %), asthenia (3.5 %), abnormal liver function test (1.8 %), stomatitis (0.9 %). Our results confirm that treatment with eribulin is feasible and safe in real-world patients." @default.
• W2254119765 created "2016-06-24" @default.
• W2254119765 creator A5009199625 @default.
• W2254119765 creator A5014536795 @default.
• W2254119765 creator A5015046932 @default.
• W2254119765 creator A5019107001 @default.
• W2254119765 creator A5023610175 @default.
• W2254119765 creator A5029995476 @default.
• W2254119765 creator A5030013928 @default.
• W2254119765 creator A5035471408 @default.
• W2254119765 creator A5041489599 @default.
• W2254119765 creator A5041815917 @default.
• W2254119765 creator A5045435601 @default.
• W2254119765 creator A5057001950 @default.
• W2254119765 creator A5085554857 @default.
• W2254119765 date "2016-01-21" @default.
• W2254119765 modified "2023-09-24" @default.
• W2254119765 title "Eribulin in pretreated metastatic breast cancer patients: results of the TROTTER trial—a multicenter retrospective study of eribulin in real life" @default.
• W2254119765 cites W1858568413 @default.
• W2254119765 cites W2034121120 @default.
• W2254119765 cites W2074890479 @default.
• W2254119765 cites W2095832858 @default.
• W2254119765 cites W2102838762 @default.
• W2254119765 cites W2106580933 @default.
• W2254119765 cites W2113498827 @default.
• W2254119765 cites W2117775530 @default.
• W2254119765 cites W2123851255 @default.
• W2254119765 cites W2125666438 @default.
• W2254119765 cites W2127152525 @default.
• W2254119765 cites W2127287298 @default.
• W2254119765 cites W2132049943 @default.
• W2254119765 cites W2132445915 @default.
• W2254119765 cites W2156513436 @default.
• W2254119765 cites W2159274183 @default.
• W2254119765 cites W2166780089 @default.
• W2254119765 cites W4230263812 @default.
• W2254119765 doi "https://doi.org/10.1186/s40064-016-1700-0" @default.
• W2254119765 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4720621" @default.
• W2254119765 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26835238" @default.
• W2254119765 hasPublicationYear "2016" @default.
• W2254119765 type Work @default.
• W2254119765 sameAs 2254119765 @default.
• W2254119765 citedByCount "33" @default.
• W2254119765 countsByYear W22541197652016 @default.
• W2254119765 countsByYear W22541197652017 @default.
• W2254119765 countsByYear W22541197652018 @default.
• W2254119765 countsByYear W22541197652019 @default.
• W2254119765 countsByYear W22541197652020 @default.
• W2254119765 countsByYear W22541197652021 @default.
• W2254119765 countsByYear W22541197652022 @default.
• W2254119765 crossrefType "journal-article" @default.
• W2254119765 hasAuthorship W2254119765A5009199625 @default.
• W2254119765 hasAuthorship W2254119765A5014536795 @default.
• W2254119765 hasAuthorship W2254119765A5015046932 @default.
• W2254119765 hasAuthorship W2254119765A5019107001 @default.
• W2254119765 hasAuthorship W2254119765A5023610175 @default.
• W2254119765 hasAuthorship W2254119765A5029995476 @default.
• W2254119765 hasAuthorship W2254119765A5030013928 @default.
• W2254119765 hasAuthorship W2254119765A5035471408 @default.
• W2254119765 hasAuthorship W2254119765A5041489599 @default.
• W2254119765 hasAuthorship W2254119765A5041815917 @default.
• W2254119765 hasAuthorship W2254119765A5045435601 @default.
• W2254119765 hasAuthorship W2254119765A5057001950 @default.
• W2254119765 hasAuthorship W2254119765A5085554857 @default.
• W2254119765 hasBestOaLocation W22541197651 @default.
• W2254119765 hasConcept C121608353 @default.
• W2254119765 hasConcept C126322002 @default.
• W2254119765 hasConcept C141071460 @default.
• W2254119765 hasConcept C143998085 @default.
• W2254119765 hasConcept C167135981 @default.
• W2254119765 hasConcept C197934379 @default.
• W2254119765 hasConcept C2775930923 @default.
• W2254119765 hasConcept C2776387010 @default.
• W2254119765 hasConcept C2776694085 @default.
• W2254119765 hasConcept C2777063308 @default.
• W2254119765 hasConcept C2778375690 @default.
• W2254119765 hasConcept C2778850193 @default.
• W2254119765 hasConcept C530470458 @default.
• W2254119765 hasConcept C71924100 @default.
• W2254119765 hasConcept C90924648 @default.
• W2254119765 hasConceptScore W2254119765C121608353 @default.
• W2254119765 hasConceptScore W2254119765C126322002 @default.
• W2254119765 hasConceptScore W2254119765C141071460 @default.
• W2254119765 hasConceptScore W2254119765C143998085 @default.
• W2254119765 hasConceptScore W2254119765C167135981 @default.
• W2254119765 hasConceptScore W2254119765C197934379 @default.
• W2254119765 hasConceptScore W2254119765C2775930923 @default.
• W2254119765 hasConceptScore W2254119765C2776387010 @default.
• W2254119765 hasConceptScore W2254119765C2776694085 @default.
• W2254119765 hasConceptScore W2254119765C2777063308 @default.
• W2254119765 hasConceptScore W2254119765C2778375690 @default.
• W2254119765 hasConceptScore W2254119765C2778850193 @default.
• W2254119765 hasConceptScore W2254119765C530470458 @default.
• W2254119765 hasConceptScore W2254119765C71924100 @default.
• W2254119765 hasConceptScore W2254119765C90924648 @default.
• W2254119765 hasIssue "1" @default.
• W2254119765 hasLocation W22541197651 @default.
• W2254119765 hasLocation W22541197652 @default.
• W2254119765 hasLocation W22541197653 @default.
• W2254119765 hasLocation W22541197654 @default.

• next